Cilostazol

• Background:

  Cilostazol is a clinically approved phosphodiesterase III (PDE3) inhibitor (IC50 = 0.2 µM) and anti-thrombotic agent. It inhibits platelet aggregation and is a direct arterial vasodilator.

• Conjugation:

  Unconjugated

• Buffer:

  White solid

• Storage Conditions:

  RT